Clinical Trials Logo

Premature Birth clinical trials

View clinical trials related to Premature Birth.

Filter by:

NCT ID: NCT01785238 Completed - Clinical trials for Neonatal Acute Renal Failure in Preterm

Nephronic Reduction After Neonatal Acute Renal Failure in Preterm

IRENEO
Start date: February 2013
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the signs of nephronic reduction in preterm infants who have presented neonatal acute renal failure. The investigators hypothesize that signs of nephronic reduction would appear earlier in former preterm with neonatal acute renal failure than in control preterm infants.

NCT ID: NCT01784835 Completed - Prematurity Clinical Trials

Early Exposure to OMT Prevents Long LOS

Start date: October 2010
Phase: N/A
Study type: Interventional

The application of osteopathic manipulative treatment (OMT) in preterm infants has been demonstrated to be effective in reducing length of stay (LOS). The scope of the present study is to investigate the association between earlier exposure to OMT and reduction of LOS in premature infants

NCT ID: NCT01783041 Completed - Prematurity Clinical Trials

Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants

Start date: January 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Preterm infants are vulnerable to brain injury, nutritional deficiencies and poor early growth which places them at increased risk for developmental problems later in life. The micronutrient carnitine, which is present in breast milk and stored in the fetus late in pregnancy, has been shown to protect against brain injury in animal studies. Without supplementation, almost all preterm infants develop carnitine deficiency soon after birth. Thus it is important to determine if carnitine supplementation protects against brain injury and improves developmental outcomes in these vulnerable preterm infants. We hypothesize that preterm infants supplemented early with L-carnitine while receiving parenteral nutrition will not develop carnitine deficiency and will have improved growth in the first two weeks of life and higher scores on developmental tests when compared to control infants who did not receive carnitine.

NCT ID: NCT01780155 Completed - Clinical trials for Bronchopulmonary Dysplasia

Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity

Start date: June 24, 2013
Phase:
Study type: Observational

Background: - Some premature babies develop bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). BPD and ROP are long-term chronic diseases of the lungs and eyes, respectively. BPD is associated with receiving mechanical ventilation to treat respiratory distress syndrome, and causes lung inflammation and scarring. ROP is caused by poor development of blood vessels in the eyes, and may lead to blindness. Because not all premature babies develop BPD or ROP, researchers want to study the genes that could be associated with these diseases. They will look at both premature infants and their parents to see if there is a genetic component to BPD and ROP. Objectives: - To study genes that may be associated with BPD and ROP. Eligibility: - Premature babies born with a weight less than or equal to 1,250 grams. - Parents of the premature babies. Design: - Parents will answer questions about the mother s health and pregnancy. - Delivery and medical information will be collected during the baby s hospitalization for the first month after birth. - Parents will provide a saliva sample from the inside of the cheek. - A saliva sample will also be collected from the baby within 28 days of birth. If the baby needs tracheal aspiration (removal of fluid from the throat), tracheal fluid samples will also be collected. - Parents will have followup interviews about their child s health 6 months, 12 months, and yearly for up to 6 years after birth. - This is a genetic study only. Treatment will not be provided as part of this study.

NCT ID: NCT01778101 Completed - Preterm Infants Clinical Trials

Lansoprazole in Preterm Infants With Reflux

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux documented by 24hr pH impedance monitoring

NCT ID: NCT01776281 Completed - Preterm Clinical Trials

Effects of Kangaroo Mother Care Among Low Birth Weight (LBW) and Preterm Infants

KMC
Start date: March 2012
Phase: Phase 2
Study type: Interventional

- Hypothermia, infections ,and ineffective breastfeeding are some of the commonest causes of deaths among premature and low birth weight LBW infants. Even if the infants are born in facilities, incidences of cold stress are possible due to insufficient resources, space and incompetent practices to manage hypothermia in the immediate postnatal period. Kangaroo Mother Care is a well-known intervention to address the issues related to preterm births, such as hypothermia, infection and prolong hospitalization.Besides significant outcome of KMC interventions for preterm infants, no interventional study has been found in literature in Pakistani context. Looking at the potential benefits of KMC in reducing the related complications of prematurity, the study aims to identify the effectiveness of KMC among preterm and LBW infants born in secondary hospital of Aga khan University hospitals. Hypothesis I Ha: KMC is effective in reducing the incidences of hypothermia among preterm and LBW infants as compared to the usual care. Hypothesis II Ha: There is a difference in breastfeeding behavior and breastfeeding outcome among experimental and control group. Secondary Hypothesis Hypothesis I Ha: There is an association between KMC and frequency of suspected infections during hospitalization. Hypothesis II Ha: There is a difference in length of stay among experimental group and control group. Hypothesis III Ha: There is a relationship between KMC and weight gain of infants till four weeks. Hypothesis IV Ha: There is difference in rate of hypothermia among experimental group and control after discharge from hospital.

NCT ID: NCT01773135 Completed - Clinical trials for Threatened Preterm Labor

Maternal Serum Level of ACTH as a Predictive Marker of Preterm Labor in Patients With Threatened Preterm Labor

PTL
Start date: January 2013
Phase: N/A
Study type: Observational [Patient Registry]

The aim of this study is use of ACTH as a predictive marker in patients of threatened preterm labor .

NCT ID: NCT01771588 Completed - Premature Birth Clinical Trials

Human Milk Fortifier - Growth Evaluation

Start date: April 2011
Phase: N/A
Study type: Interventional

It it is hypothesized that the growth of preterm infants receiving a new human milk fortifier will be equal or superior to the growth of preterm infants receiving a currently marketed human milk fortifier with a lower protein content.

NCT ID: NCT01766908 Completed - Preterm Birth Clinical Trials

Optimal Timing of Cord Clamping in Preterm Pregnancy Following Vaginal or Cesarean Delivery

CordClamp
Start date: December 2012
Phase: N/A
Study type: Interventional

This is an experimental research study for pregnant women between 23 and 37 weeks age of gestation who will be having a baby sooner than term. This study is to learn if waiting 20, 40, or 60 seconds to clamp the umbilical cord after baby delivers will improve his/her outcome and overall health. Benefit to the baby may come by increasing the amount of blood in the baby's body, reducing the need for possible transfusion later, and possible prevention of other complications caused by too little blood in the baby. Possible reduction of cerebral palsy may be realized by a longer interval for cord clamping.

NCT ID: NCT01764958 Completed - Premature Birth Clinical Trials

Association Between Mother-Infant Attunement During Interaction and the Quality of General Movements

Start date: April 2012
Phase: N/A
Study type: Observational [Patient Registry]

The proposed research has the potential of contributing to the limited empirical literature on the relationship between maternal sensitivity and motor development of preterm infants. If indeed maternal attuned behaviors will be found to be associated with the quality of motor development, such a finding will support the effectiveness of physical therapy in guiding caregivers to attune their holding and touch of preterm infants. We hypothesize that mothers and infants' attunement during observed interaction will be related to the quality of preterm infants' spontaneous movements in the following ways: First, better maternal attunement to the infants needs, and in particular attunement of holding and touch will be associated with better quality of spontaneous movements of the infants. Second, more initiations and/or involvement of infants in interaction will be associated with better maternal attunement to the infant. Third, more initiations and/or involvement of infants in interaction will be associated with better quality of spontaneous movements and better achievements in developmental milestone. All hypotheses will be examined while controlling for maternal use of SSC method during hospitalization after birth and family demographic backgrounds.